Medical Robots Market worth 13 Billion USD by 2023, by registering a CAGR of 21.5%- Research Nester

Research Nester has recently announced its latest Industry research on "Medical Robotics Market: Global Demand Analysis & Opportunity Outlook 2023"Medical robots allows surgeons to carry out operations in more precise and less invasive way, medical robots increases accuracy of the operation along with wide range of advantages such as decreases risk of infection, decreases post-operative pain and reduces risk of patients life. Along with improved patient care, another aim of making medical robotics mainstream is to cut down on medical costs along with improved diagnostic abilities. The world is currently facing the shortage medical facilities; robots such as Aethon TUG can complete the work of three full-time employees this can save the man power for other activities. Adoption of medical robotics in healthcare industry is considered as a wise step to overcome the global shortage of medical facilities. Medical robots are mainly used because of their ability to perform repetitive tasks at high speeds, reliably and without fatigue.The robotic method poses great benefits, not only in terms of performance, but also in terms of cost-effectiveness, ease of use and other such factors.

Market Size & Forecast

In 2015, the global robotics market was valued at USD 4.1 billion and the market is anticipated to reach USD 13 billion by the end of 2023 witnessing a compound annual growth rate of 21.5% over the period of forecast.

Geographically, North America is anticipated to have the upper hand over the global market in terms of revenue share owing to increasing investment in R&D activities coupled with rapid technological advancement in healthcare industry in the region.

In terms of market growth, Asia Pacific is anticipated to be the most attractive market witnessing a compound annual growth rate of 17% over the forecast period i.e. 2016-2023. This is mainly attributed towards the development of medical infrastructure in the region.

Surgical robots segment accounted for the highest market share of 40% in 2015, the market is anticipated to expand with a promising compound annual growth rate over the forecast period. This can be attributed towards the increasing acceptance of medical robots in cardiac, orthopedic, and neurosurgery.

The rehabilitation robotics segment is expected to exhibit the fastest growth, with a compound annual growth rate of 20% during the forecast period. Rehabilitation robots are gaining popularity due to the rising aging population subject to increasing physical disabilities and this will further expand the demand of rehabilitation robots over the forecast period i.e. 2016-2023.

In robotic surgery, the robot is initially programmed and allowed to proceed on its own; there are some other applications of robotics in surgery where the robot is actually guided by surgeons throughout the process. The actions of the robot are not predetermined, but rather controlled in real-time by the surgeon.

Growth Drivers and Challenges

The rising need of advance technology in healthcare industry, increasing patient pool and extensive application of medical robots in critical surgeries such as cardiac, orthopedic, and neurosurgery are some of factors that drives the medical robotics market across the globe.

Favourable government reforms towards the development of healthcare industry such as Patient Protection and Affordable Care Act (PPACA) based in U.S which encourages the market players to adopt technologically advanced treatment methods, the act provide incentives to the hospitals to promote the adoption of advance medical treatment in order to improve the quality of medical services in the country is anticipated to propel the market growth. Government of developing countries are also taking initiatives to develop the medical infrastructure of the country, this will further expand the medical robotics market in public sector.

Increasing acceptance of medical robotics in healthcare industry along with the increasing contribution of medical robots in complex cases is anticipated to fuel the demand of medical robotics in the upcoming 5-6 years.

Various advantages gained by automation of medical practices such as speed, accuracy, repeatability, reliability, and cost-efficiency will further spur the demand of medical robots in hospitals.

Reluctance to accept robotics in medical sector along with the safety concerns, high cost of the medical robots are some factors that are restraining the market growth. 

To know more about this research, kindly visit:

http://www.researchnester.com/reports/medical-robotics-market-global-demand-growth-analysis-opportunity-outlook-2023/206

For Table of Content & Free Sample Report Contact:

Ajay Daniel

Email: ajay.daniel@researchnester.com

U.S. +1 646 586 9123

U.K. +44 203 608 5919

Veterinary Drug Market expected to worth USD 49.8 Billion by 2023, globally- Research Nester

Worldwide, veterinary (animal drug / medicine) drug market to grow at a CAGR of 6.8% during 2015-2023.Global veterinary drug market is segmented into medicated feed additives such as amino acids and antibiotics. Among these segments, antibiotics segment is expected to be the fastest growing market owing to cost-effectives and ease of availability.

The global veterinary drug market is predicted to flourish significantly at a CAGR of 6.8% over the forecast period i.e. 2016-2023. Moreover, the market of veterinary drug accounted for USD 25.3 Billion in 2015.

North America has accounted the largest market revenue share in 2015 in veterinary drug market across the globe owing to introduction of affordable and advanced veterinary drug in the market by several key players in the region. However, the market of Asia-Pacific is estimated to fastest growing market over the forecast period attributed to increasing adoption of medicated feed additives for pet and livestock companions by the owners.

Advancements in Veterinary Drug:

Introduction of advanced cost effective veterinary drug, rising clinical researches in order to treat diseases and other disorders of animals, increases safety and effectiveness of veterinary drug thus swelled the demand for veterinary drug globally. Other than this, rise in gross disposable income of population across the globe is likely to spend more on animal healthcare by the pet owners.

Rising concern towards animal healthcare:

Rising awareness towards healthcare and well-being of livestock companion and pets and introduction of animal immunization policies by the government organizations in many developing nations such as China are likely to shift consumers from conventional treatments to advance and effective veterinary drugs. Moreover, the market is driven by the factors such as growing initiatives from government authorities to develop cost effective and safe drugs in order to minimize the animal diseases burden in terms of animal suffering

However, increasing cost of animal healthcare, growing variety of diseases in animals, rapid growth in urbanization leads to congested cities coupled with higher risk of severe diseases, huge expenditure needed in research and development of veterinary drugs are some of the factors likely to inhibit the growth of veterinary drugs market in near future.

The report titled “Global Veterinary Drug Market Outlook 2023” delivers detailed overview of the Global Veterinary Drug Market in terms of market segmentation by product type, by route of administration, by animal type, by End-user.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

This report also provides the existing competitive scenario of some of the vendors of the Global Veterinary Drug Market which includes company profiling of Bayer Animal Health, Ceva Animal Healthcare, Elanco Animal Health, Merck Ltd., Merial Animal Health, etc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview on the Global Veterinary Drug Market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

To know more about this research, kindly visit:

http://www.researchnester.com/reports/veterinary-animal-drug-drug-market-global-demand-growth-analysis-opportunity-outlook-2023/186

For Table of Content & Free Sample Report Contact:

Ajay Daniel

Email: ajay.daniel@researchnester.com

U.S. +1 646 586 9123

U.K. +44 203 608 5919

Global Autoclave market demand is anticipated to reach USD 2.3 billion by 2023- Research Nester

Global Autoclave market is majorly driven by increasing number of industrial application and strong demand from research and development laboratories according to our research report “Global Autoclave Market Outlook 2023”

The global autoclave market is anticipated to reach USD 2.3 billion by the end of 2023; the market is expected to witness a promising compound annual growth rate of 7.1% over the forecast period.

Asia-Pacific region dominates the global autoclave market in terms of revenue share, Asia Pacific autoclave market is anticipated to reach USD 810 million by the end of 2023. This can be attributed towards the rapid migration of R&D companies in the region. International companies from Europe and North America are shifting their R&D laboratories in Asia Pacific region.

Increasing Number of Industrial Application: Up Thrust

Increasing industrial application coupled with strong demand of autoclaves in R&D projects is driving the autoclave market across the globe. Majority of the sales of autoclaves comes from research and industrial firms; this will further propel the market growth over the forecast period.

Strong Demand From Research and Development Laboratories: Momentum

Government initiatives towards the sanitation and proper disposal of medical waste has forced the healthcare industry to adopt proper sanitation techniques, this has increased the demand of autoclaves in healthcare industry.  Increasing demand of autoclaves in tattooing and piercing industry, along with rising awareness of consumers towards spread of communicable diseases by equipment that are used in unhygienic manner is propelling the market growth across the globe.

The report titled “Global Autoclave Market Outlook 2023” delivers detailed overview of the global autoclave market in terms of market segmentation by product type, by source and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

This report also provides the existing competitive scenario of some of the vendors of the Global autoclave market which includes company profiling of Astell Scientific, Benchmark Scientific, Panasonic Biomedical etc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview on the Global Autoclave Market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

To know more about this research, kindly visit:

http://www.researchnester.com/reports/autoclave-market-global-demand-growth-analysis-opportunity-outlook-2023/221

 For Table of Content & Free Sample Report Contact:

Ajay Daniel

Email: ajay.daniel@researchnester.com

U.S. +1 646 586 9123

U.K. +44 203 608 5919

3D Printed Medical Device Market to reach USD 2.20 Billion by 2021, globally- Research Nester

Research Nester has recently announced new market demand assessment research titled ”Global 3D Printed Medical Device market–Demand, Opportunity, Growth, Future Prospects and Competitive Analysis, 2015–2021”. 3D printing also known as additive manufacturing is a procedure of creating three dimensional hard objects using digital file. The formation of a 3D printed object is completed by means of additive processes. 3D printing is now majorly being used in various industrial sectors including manufacturing, healthcare and automotive all over the world.

The global 3D printed medical device market is envisioned to reach USD 2.20 Billion over the forecast period i.e. 2015-2021, exhibiting a compound annual growth rate (CAGR) of 25.6%. Geographically, the global 3D printed medical device market is segmented into North America, Latin America, Western and Eastern Europe, Asia-Pacific, Middle East and North Africa (MENA) and Rest of World.

Growth drivers and challenges

Technical innovations in 3D printing, increasing government support, and increasing applications of 3D-printed organs in organ transplantation surgeries are expected to be the main growth drivers of global 3D printed medical device market over the forecast period i.e. 2015-2021.

In addition to that, escalating demand of organ transfer coupled with mergers and collaborations in 3D printing market are believed to garner the global 3D printed medical device market during 2015-2021.

However, high cost involved in 3D printing system and specific skills required to operate 3D printing technology are few of the major challenges which are expected to hamper the growth of global 3D printed medical device market in future.

Market size

With 37% of share in 2015, North America dominated the global 3D printed medical device market. The market in the region is anticipated to flourish owing to growing awareness in patients, expanding health care spending and rising expenditure on research and development.

Europe is the second largest 3D printed medical devices market behind North America. The market in the region is expected to augment from rising demands of customized medical instruments and devices.

The Asia-Pacific 3D printed medical device market is estimated to nurture at highest CAGR over the period of 2015-2021 sparked by expanding government budget to improve establishment of 3D printing research centers in countries such as India and China.

Key Players

The global 3D printed medical devices market encompasses some of the key players including Stratasys Inc., Envision TEC, Materialise NV, Robohand, Worrell, Rainbow Biosciences, etc.

To know more about this research, kindly visit:

http://www.researchnester.com/reports/3d-printed-medical-device-market-global-demand-analysis-opportunity-outlook-2021/20

For Table of Content & Free Sample Report Contact:

Ajay Daniel

Email: ajay.daniel@researchnester.com

U.S. +1 646 586 9123

U.K. +44 203 608 5919